Drug recall
Buprenorphine HCl, a) 0.3 mg/mL 100 mL suspension NDC 3330099470; b) 0.3 mg/mL 100 mL (chicken) suspension NDC…
FDA recall event 86016 · Class II · US Compounding Inc
Key facts
| Event ID | 86016 |
|---|---|
| Recall numbers | V-0463-2020 |
| Recalling firm | US Compounding Inc |
| Product type | Veterinary |
| Products | Buprenorphine HCl, a) 0.3 mg/mL 100 mL suspension NDC 3330099470; b) 0.3 mg/mL 100 mL (chicken) suspension NDC 33300984470; c) 0.3 mg/mL 100 mL (flavorless) suspension NDC 33300002670; d) 0.3 mg/mL30… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | API used beyond the manufacturer's expiration date. |
| Initiation date | Jul 1, 2020 |
| Report date | Jul 29, 2020 |
| Termination date | Nov 5, 2021 |
| City | Conway |
| State | AR |
| Country | United States |
| FEI number | 3006031801 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: